Quantum Genomics Société Anonyme

ENXTPA:ALQGC Stock Report

Market Cap: €4.6m

Quantum Genomics Société Anonyme Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Jean-Philippe Milon

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure6.1yrs
CEO ownership2.2%
Management average tenureno data
Board average tenure2.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Jean-Philippe Milon's remuneration changed compared to Quantum Genomics Société Anonyme's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-€3m

Sep 30 2023n/an/a

-€11m

Jun 30 2023n/an/a

-€18m

Mar 31 2023n/an/a

-€22m

Dec 31 2022n/an/a

-€25m

Sep 30 2022n/an/a

-€22m

Jun 30 2022n/an/a

-€20m

Mar 31 2022n/an/a

-€19m

Dec 31 2021€1m€246k

-€17m

Sep 30 2021n/an/a

-€18m

Jun 30 2021n/an/a

-€18m

Mar 31 2021n/an/a

-€17m

Dec 31 2020€863k€240k

-€16m

Sep 30 2020n/an/a

-€14m

Jun 30 2020n/an/a

-€10m

Mar 31 2020n/an/a

-€10m

Dec 31 2019€378k€236k

-€10m

Compensation vs Market: Insufficient data to establish whether Jean-Philippe's total compensation is reasonable compared to companies of similar size in the French market.

Compensation vs Earnings: Jean-Philippe's compensation has increased whilst the company is unprofitable.


CEO

Jean-Philippe Milon (63 yo)

6.1yrs

Tenure

€1,433,077

Compensation

Dr. Jean-Philippe Milon, PhD., has been the Chief Executive Officer at Quantum Genomics Société Anonyme since April 06, 2018, and serves as its MD, and has also been its Director since June 17, 2019. Dr. M...


Board Members

NamePositionTenureCompensationOwnership
Jean-Philippe Milon
CEO, MD & Chairman4.9yrs€1.43m2.17%
€ 99.9k
George L. Bakris
Member of Scientific & Clinical Advisory Board1.9yrsno datano data
Lionel Segard
Directorno data€295.81k2.01%
€ 92.4k
Alexandre Persu
Member of Scientific & Clinical Advisory Boardno datano datano data
Keith Ferdinand
Member of Scientific & Clinical Advisory Board8.3yrsno datano data
François Pelen
Independent Director2.3yrsno datano data
Carole Wassermann
Director6.3yrsno datano data
Gregory Lip
Member of Scientific & Clinical Advisory Board1.9yrsno datano data
Atul Pathak
Member of Scientific & Clinical Advisory Board1.9yrsno datano data
Francois Durvye
Director2.3yrsno datano data

2.3yrs

Average Tenure

60.5yo

Average Age

Experienced Board: ALQGC's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.